These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 34305430)

  • 21. Clinical Characteristics and Predictors of 28-Day Mortality in 352 Critically Ill Patients with COVID-19: A Retrospective Study.
    Alharthy A; Aletreby W; Faqihi F; Balhamar A; Alaklobi F; Alanezi K; Jaganathan P; Tamim H; Alqahtani SA; Karakitsos D; Memish ZA
    J Epidemiol Glob Health; 2021 Mar; 11(1):98-104. PubMed ID: 33095982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors Affecting the Length of Stay in the Intensive Care Unit among Adults in Saudi Arabia: A Cross-Sectional Study.
    Alharbi KK; Arbaein TJ; Alzhrani AA; Alzahrani AM; Monshi SS; Alotaibi AFM; Aljasser AI; Alruhaimi KT; Alotaibi SDK; Alsultan AK; Arafat MS; Aldhabib A; Abd-Ellatif EE
    J Clin Med; 2023 Oct; 12(21):. PubMed ID: 37959252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of characteristics, predictors and outcomes between the first and second COVID-19 waves in a tertiary care centre in Switzerland: an observational analysis.
    Wolfisberg S; Gregoriano C; Struja T; Kutz A; Koch D; Bernasconi L; Hammerer-Lercher A; Mohr C; Haubitz S; Conen A; Fux C; Mueller B; Schuetz P
    Swiss Med Wkly; 2021 Aug; 151():w20569. PubMed ID: 34375985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of and Outcomes in COVID-19 Critical Care Patients in the Qassim Region, Saudi Arabia.
    Alharbi RM; Selim MA; Alowayed AA; Elhassan WH
    Cureus; 2023 Nov; 15(11):e48323. PubMed ID: 38060713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival and Estimation of Direct Medical Costs of Hospitalized COVID-19 Patients in the Kingdom of Saudi Arabia.
    Khan AA; AlRuthia Y; Balkhi B; Alghadeer SM; Temsah MH; Althunayyan SM; Alsofayan YM
    Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33066327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inpatient Hospital Costs for COVID-19 Patients in the United States.
    Ohsfeldt RL; Choong CK; Mc Collam PL; Abedtash H; Kelton KA; Burge R
    Adv Ther; 2021 Nov; 38(11):5557-5595. PubMed ID: 34609704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effectiveness and Safety of Direct-Acting Antivirals in the Treatment of Hepatitis C Virus in Saudi Arabia: A Nationwide Study Based on the Saudi Ministry of Health Surveillance Data From 2017 to 2021.
    Al-Ahmari TS; Alotaibi AF; Aljasser AI; Aljasser AI; Eldaw AM; Abd-Ellatif EE
    Cureus; 2023 Aug; 15(8):e42780. PubMed ID: 37664260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and epidemiological characteristics of COVID-19 mortality in Saudi Arabia.
    Alsayer RM; Alsharif HM; Al Baadani AM; Kalam KA
    Saudi Med J; 2021 Oct; 42(10):1083-1094. PubMed ID: 34611003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticoagulation dosage strategy therapy, length of stay, and all-cause mortality in critically ill COVID-19 patients admitted to the intensive care unit.
    Vennu V; Alshammary AF
    Medicine (Baltimore); 2024 Jan; 103(1):e36854. PubMed ID: 38181238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors Affecting Hospitalization Length and in-Hospital Death Due to COVID-19 Infection in Saudi Arabia: A Single-Center Retrospective Analysis.
    Al Omair OA; Essa A; Elzorkany K; Shehab-Eldeen S; Alarfaj HM; Alarfaj SM; Alabdulqader F; Aldoughan A; Agha M; Ali SI; Darwish E
    Int J Gen Med; 2023; 16():3267-3280. PubMed ID: 37546239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics and predictors of mortality among COVID-19 patients in Saudi Arabia.
    Albalawi O; Alharbi Y; Bakouri M; Alqahtani A; Alanazi T; Almutairi AZ; Alosaimi B; Mubarak A; Choudhary RK; Alturaiki W
    J Infect Public Health; 2021 Aug; 14(8):994-1000. PubMed ID: 34153731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot study of therapeutic plasma exchange for serious SARS CoV-2 disease (COVID-19): A structured summary of a randomized controlled trial study protocol.
    Faqihi F; Alharthy A; Alodat M; Asad D; Aletreby W; Kutsogiannis DJ; Brindley PG; Karakitsos D
    Trials; 2020 Jun; 21(1):506. PubMed ID: 32513290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health economic burden of COVID-19 in Saudi Arabia.
    Alenzi KA; Al-Malky HS; Altebainawi AF; Abushomi HQ; Alatawi FO; Atwadi MH; Khobrani MA; Almazrou DA; Alrubeh N; Alsoliabi ZA; Kardam AM; Alghamdi SA; Alasiri A; Albalwi MH; Alshammari TM
    Front Public Health; 2022; 10():927494. PubMed ID: 36388318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Efficacy of Hydroxychloroquine in Patients with COVID-19: Findings from an Observational Comparative Study in Saudi Arabia.
    Alghamdi S; Barakat B; Berrou I; Alzahrani A; Haseeb A; Hammad MA; Anwar S; Sindi AAA; Almasmoum HA; Albanghali M
    Antibiotics (Basel); 2021 Mar; 10(4):. PubMed ID: 33807320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of COVID-19 Patients Admitted to Intensive Care Unit in Multispecialty Hospital of Riyadh, Saudi Arabia: A Retrospective Study.
    Almuqbil M; Almoteer AI; Suwayyid AM; Bakarman AH; Alrashed RF; Alrobish M; Alasalb F; Alhusaynan AA; Alnefaie MH; Altayar AS; Alobid SE; Almadani ME; Alshehri A; Alghamdi A; Asdaq SMB
    Healthcare (Basel); 2023 Sep; 11(18):. PubMed ID: 37761697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What are the risk factors of hospital length of stay in the novel coronavirus pneumonia (COVID-19) patients? A survival analysis in southwest China.
    Wang Z; Liu Y; Wei L; Ji JS; Liu Y; Liu R; Zha Y; Chang X; Zhang L; Liu Q; Zhang Y; Zeng J; Dong T; Xu X; Zhou L; He J; Deng Y; Zhong B; Wu X
    PLoS One; 2022; 17(1):e0261216. PubMed ID: 35030181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics in Pediatric Patients with Coronavirus Disease 2019 in Korea.
    Seon JY; Jeon WH; Bae SC; Eun BL; Choung JT; Oh IH
    J Korean Med Sci; 2021 May; 36(20):e148. PubMed ID: 34032033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors associated with worse outcomes in COVID-19: a retrospective study in Saudi Arabia.
    Khan A; Althunayyan S; Alsofayan Y; Alotaibi R; Mubarak A; Arafat M; Assiri A; Jokhdar H
    East Mediterr Health J; 2020 Nov; 26(11):1371-1380. PubMed ID: 33226105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics of non-intensive care unit COVID-19 patients in Saudi Arabia: A descriptive cross-sectional study.
    Al-Omari A; Alhuqbani WN; Zaidi ARZ; Al-Subaie MF; AlHindi AM; Abogosh AK; Alrasheed AK; Alsharafi AA; Alhuqbani MN; Salih S; Alhedaithy MA; Abdulqawi R; Ismail AF; Alhumaid S; Hamdan N; Saad F; Olhaye FA; Eltahir TA; Alomari M; Alshehery M; Yassiri A; Al-Tawfiq JA; Al Mutair A
    J Infect Public Health; 2020 Nov; 13(11):1639-1644. PubMed ID: 33004305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dynamic measurement of volume of atelectasis area in the evaluation of the prognosis of patients with moderate-to-severe acute respiratory distress syndrome].
    Lu X; Han Y; Gao X; Wang F; Xu L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Sep; 32(9):1056-1060. PubMed ID: 33081890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.